BABA vs TRON

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

TRON exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. While the company maintains a strong liquidity position with a Current Ratio of 19.01 and zero debt, its valuation is disconnected from reality with an extreme Price-to-Sales ratio of 268.18. Despite 30.7% revenue growth, the company is unable to convert sales into profit, evidenced by a -34.4% operating margin. The combination of a bearish technical trend and a lack of earnings makes the current price speculative and unsustainable.